Genpact Limited Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Genpact Limited on March 21, 2017. The filing reports the pricing of a private debt offering by Genpact Luxembourg S.à r.l., a wholly owned subsidiary of Genpact.
Key Financial Metrics and Transaction Details
- Debt Issuance: $350 million aggregate principal amount of 3.700% senior unsecured notes due 2022.
- Interest Payments: Semi-annual payments on April 1 and October 1, commencing October 1, 2017.
- Guarantee: The notes are guaranteed on a senior unsecured basis by Genpact Limited.
- Use of Proceeds: Repayment of outstanding loans under the revolving credit facility and general corporate purposes (including potential acquisitions and share repurchases).
- Closing Date: Expected to close on March 27, 2017.
Material Changes and Covenants
The issuance introduces new senior unsecured debt obligations. The notes are subject to customary covenants limiting the ability to incur secured debt, engage in sale-leaseback transactions, or consolidate/merge assets. A change of control covenant requires an offer to repurchase the notes at 101% of the principal amount plus accrued interest upon a qualifying event.
Outlook, Risks, and Management Commentary
Management intends to utilize the proceeds to optimize the capital structure by reducing revolving credit facility borrowings. The interest rate is subject to adjustment based on credit rating changes by Moody's or S&P. The filing includes standard forward-looking statement disclaimers, noting that the offering is subject to market conditions and customary closing conditions, with no assurance of completion.
Investor Verification Checklist
- Confirm the closing of the $350 million notes offering on or around March 27, 2017.
- Verify the actual application of proceeds, specifically the reduction of the revolving credit facility balance.
- Monitor credit rating actions by Moody's and S&P that could trigger interest rate adjustments.
- Review the definitive Indenture for specific covenant limitations and exceptions.